Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Time-lagged multiple-dose trial of PSN9301 in type 2 diabetes mellitus
2004-002701-68Phase 2Completed
- Sponsor
- Prosidion Ltd.
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing PSN9301 arm with Placebo arm (2 arms). Primary endpoints: Pharmacodynamic endpoints, Safety and tolerability and 1 more. Started Oct 2004; status: completed.
02
Drugs
PSN9301
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-002701-68.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002701-68.